Agenda | Intelligent Health AI | September 2020 | Online

Cyber Space Agenda 2020

 

 

It’s only at Intelligent Health AI where you will find unlimited content. In partnership with our sponsors, we have created the Cyber Space agenda – extra content for you at set times, because we know your hunger for knowledge has to be fed and has to be punctual!

 

Download Cyber Space agenda

Running in Central European Time

Watch live demos and presentations and take part in discussions streamed from all corners of the world. Feed you mind with unlimited content!

DAY ONE – Wednesday 9th September 2020

 

TIME TITLE CYBERSPACE
08:30 –

08:50

Compound screening using graph convolutional networks – COVID-19 case study

Yujiro Otsuka, Representative Managing Partner, Plusman

Plusman
09:30 – 10:30 Meet the Fondation Botnar team – come with your questions

Kiara Marvuglio, Engagement and Communications Manager, Fondation Botnar

Fondation Botnar
11:00 – 11:20 A guide to selecting your first AI project  

Kamil Zalewski, AI practice lead, Unit8

UNIT8
11:20 – 11:40 Accelerating innovation from clinical trials to clinical practice with Holmusk real world data analytics

Stefan Suter, Head Europe, Holmusk 

Dr. Jordan Abdi, Strategy and Business Development Lead, Holmusk

Subina Surendran, Director of Life Sciences Partnerships, Holmusk

Moderator: Dr. Alex Knight, Project Manager, Holmusk

Holmusk
11:20 – 11:40 Combination Products according to the European Medical Device Regulation 2017/745 Article 117 (live)

Adrian Gammeter, Senior Consultant, Confinis

Confinis
11:20 – 11:40 AI for finding More Patients including undiagnosed ones for Commercial and Research in Industry

Dr. Vibhor Gupta, Director and Founder, Pangaea Data

Pangaea Data
11:30 – 11:40 Counterfeit medicines, medical products and COVID-19

Tuomas Kannas, Co-founder and SVP, TrueMed

TrueMed
11:45 – 12:00 The UK’s AI healthcare expertise: Greater London

Sura Hussein, Senior Inward Investment Manager Innovation & Life Sciences, London&Partners

London has all of the ingredients of a dynamic and innovative life sciences ecosystem: world-class higher education institutions, leading specialist and teaching hospitals, a large and diverse population, and a vibrant community of life science, digital and supply chain companies. Sura Hussein of London & Partners will showcase the region’s expertise for example in AI in cancer research, give an outline of future plans in development, and describe how L&P can help companies be part of it all.

UK’s Department for International Trade
12:05 – 12:20 UK Case Study: MedCity, AI in imaging and diagnostics

Phil Jackson, Head of International and Cluster Development, MedCity

MedCity is the cluster organisation for the world-leading health and life sciences sector in London and the Greater South East of England, set up in 2014 by the Mayor of London and the region’s Academic Health Science Centres to drive growth and investment in the sector. Phil Jackson will present specifically on the use of AI in imaging and diagnostics within the MedCity cluster, and describe the ways in which the cluster can support digital health companies.

UK’s Department for International Trade
12:15 – 12:45 Regulatory all you can eat 1: open live Q&A session

Martina Coscia, Consultant, Confinis

Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis

Confinis
12:30 –

12:50

Lung nodule management and response evaluation of molecular targeted agents for non-small cell lung cancer by 3D U-net deep learning model

Yusuke Nakamura, Managing Partner, Plusman

Plusman
13:20 –

13:40

Democratizing access to mental health data and analytics in a single platform: NeuroBlu

Sankha S. Mukherjee, Ph.D., Senior Data Scientist, Holmusk

Rajagopalan Ramaswamy, Ph.D., Senior Data Scientist, Holmusk

Moderator: Dr Rashmi Patel MD PhD, CMO (Europe), Holmusk

Holmusk
13:20 –

13:40

AI to Extract Intelligence from Doctors Notes

Dr. Julia Ive, Head of NLP, Pangaea Data

Pangaea Data
14:00 – 14:30 Extended Q&A – USE CASE 1: Privacy preserving federated learning for AI in healthcare with an application to semantic segmentation of computed tomography (CT) scans of vertebrae

Dr. Gabriel Krummenacher, Team Lead Data Science, Zuehlke Group

Tomas Dikk, Lead Data Science, Zuehlke Group

Roland Herzog, Head Technology Transfer, AO Foundation

Zühlke
14:05 – 14:20 Digitize health care value chain

Florent Bouguin, CTO, Optel Group

Optel
14:00 – 14:25 Chronolife: Innovative Digital Health solutions paired with Predictive algorithm

Nicolas Wojciechowski, Sales Country Manager, Chronolife

Chronolife
14:30 – 14:50 GenAIz Overview

Raagi Pandya, Director, Product & Development, GenAIz

GenAIz
14:40 – 15:40 Meet AlpVision – come with questions!

Dr. Fred Jordan, CEO, AlpVision

AlpVision
15:00 – 15:15 The UK’s AI healthcare expertise: Greater Manchester

Catherine Davidson, Head of Business Development, MIDAS

The Greater Manchester area is one of the UK’s most exciting hubs of innovation for digital health, and offers particular expertise in health analytics and medtech. Catherine Davidson of MIDAS, Manchester’s Investment Agency, will highlight opportunities for companies active in AI in healthcare, and describe ways MIDAS can support those companies in the region.

UK’s Department for International Trade
15:20 – 15:35 UK case study: Salford Royal NHS Foundation Trust’s Digital Control Centre

James Ritchie, CCIO, DCC Programme Lead

Salford Royal NHS Trust is a leading e-enabled NHS trust in England. The Digital Control Centre programme, launched in 2019, is a 10 year project to revolutionise the organisation of care across its acute and integrated services. Jim Ritchie, consultant kidney doctor and lead for the DCC programme, will describe the scope and initial delivery of this major transformation programme.

UK’s Department for International Trade
15:30 – 15:40 Live demo of confinis’ Atlassian-based paperless electronic Quality Management System (live)

Stefano Adami, Competence Cluster Lead & Senior Consultant, Confinis

Confinis
15:30 – 15:50 Value of Causal AI in Cardiovascular and Chronic Kidney Disease

Dr. Abhijit Ghosh, Senior Data Scientist, Holmusk

Subina Surendran, Director of Life Sciences Partnerships, Holmusk

Armita Afsharinejad, Associate Director Data Science, Novartis

Moderator: Dr. Alex Knight, Project Manager, Holmusk

Holmusk
15:40 – 15:50 Counterfeit medicines, medical products and COVID-19

Tuomas Kannas, Co-founder and SVP, TrueMed

TrueMed
15:40 – 15:50 New Career Opportunities in AI and Healthcare with serial entrepreneurs 

Mr. Jingqing Zhang, Head of AI, Pangaea Data

Dr. Zhihua Wang, Head of Product, Pangaea Data

Pangaea Data
16:05 – 16:15 UK Company Pitch: Ampersand Health

Aahuti Rai, Chief Strategy & Growth Officer

Ampersand Health is creating the first clinically-validated, behavioural science-based digital therapeutics for inflammatory conditions. Their apps use behavioural- and data-science to support improvements in sleep, mental health and adherence for people living with an inflammatory condition. Ampersand Health is recognised in the Digital Health Global 100, and has won an HSJ Award, the NHS Ideas Lab, the NHS Hackfest and competitive grants from government and industry. 

UK’s Department for International Trade
17:00 – 17:20 FDA’s Regulatory Oversight on AI and Digital Health (live)

Viky Verna, Co-Founder and VP, Confinis

Confinis

 

DAY 2 – Thursday 10th September 2020

TIME TITLE CYBERSPACE
08:30 – 08:50 Compound screening using graph convolutional networks – COVID-19 case study

Yujiro Otsuka, Representative Managing Partner, Plusman

Plusman
08:30 – 09:00 Regulatory all you can eat 1: open live Q&A session

Martina Coscia, Consultant, Confinis

Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis

Confinis
09:00 – 09:20 Lung nodule management and response evaluation of molecular targeted agents for non-small cell lung cancer by 3D U-net deep learning model

Yusuke Nakamura, Managing Partner, Plusman

Plusman
09:00 – 10:00 Meet AlpVision – come with your questions! 

Dr. Martin Kutter, President, AlpVision

AlpVision
09:30 – 09:40 UK Company Pitch: Kraydel

Amer Fasihi, CEO & Co-Founder, Kraydel

Kraydel, the leader in Agetech, improves the quality of life and independence of their users, by tackling social isolation, supporting a proactive approach to well-being and resilience, and through their platform, enabling the provision of services to address digital exclusion.

UK’s Department for International Trade
09:50 – 10:00 UK Company Pitch: DDM (Diabetes Digital Media)

Arjun Panesar, CEO

DDM provide evidence-based digital therapeutics (apps) that engage patients and improve clinically health outcomes in 7 markets and 6 languages. Outcomes include weight loss, improved blood glucose control, type 2 diabetes remission, and reduction in symptoms of anxiety, stress and depression. Their award-winning solutions are available on a range of platforms including iOS, Android, Apple and Android watch, Amazon Alexa and in VR on Oculus Rift and HTC Vive.

UK’s Department for International Trade
10:10 – 10:20 UK Company Pitch: Cievert

Alex Blakoe, COO, Cievert

Cievert has developed technology to enhance a wide variety of clinical disciplines, from referral management to patient follow-up and consultations. The rich data accumulated is being used to develop an AI-enabled platform that stratifies risk, detecting conditions earlier. By applying machine learning to clinical pathways, this platform can also continuously inform and thus improve treatment using real world data, optimising and personalising healthcare.

UK’s Department for International Trade
10:30 – 10:40 UK Company Pitch: Farmatrust  

Raja Sharif, CEO

FarmaTrust provides future-proof blockchain and AI based provenance systems for the pharmaceutical and healthcare sector. FarmaTrust digital solutions and services create efficiencies, accountability and transparency for supply chains, ease the burden of compliance requirements, reduce costs and eliminate counterfeit or substandard products.   

UK’s Department for International Trade
10:55 – 11:15 Jumping the innovation chasm – from AI-lab to diagnostics product in 6 months.

Boris Langer, Senior Business Solution Manager, Zühlke

There are plenty of ideas on how to use machine learning for a better health system. Only few of them make it to the market. Many brilliant prototypes fall prey to discordant stakeholders, ambitious quality requirements or strict data protection policies. Together with one of our customers we managed to get from a research prototype to a fully FDA compliant software application in only 6 months. In this presentation we want to outline the main obstacles we encountered and how we overcame them.

Zühlke
10:55 – 11:15 Introduction on cybersecurity within the European Medical Device Regulation (live)

Martina Coscia, Consultant, Confinis

Confinis
10:55 – 11:15 AI to Extract Intelligence from Doctors Notes

Dr. Julia Ive, Head of NLP, Pangaea Data

Pangaea Data
11:00 – 11:20 A guide to selecting your first AI project  

Kamil Zalewski, AI practice lead, Unit8

UNIT8
11:00 – 11:25 Chronolife: Innovative Digital Health solutions paired with Predictive algorithm

Nicolas Wojciechowski, Sales Country Manager, Chronolife

Chronolife
11:00 – 12:00 Meet the Fondation Botnar team – come with your questions

Kiara Marvuglio, Engagement and Communications Manager, Fondation Botnar

Fondation Botnar
11:25 – 11:45 Real world data enrichment using Natural Language Processing and Advanced Predictive Analytics

Joydeep Sarkar, Chief Analytics Officer, Holmusk

Jesisca Tandi, Data Scientist, Holmusk

Moderator: Dr Rashmi Patel MD PhD, CMO (Europe), Holmusk

Holmusk
12:25 – 12:40 The UK’s AI healthcare expertise: AI in healthy ageing

Julie Taylor, Ageing Society Specialist, UK’s Department for International Trade

The UK’s Industrial Strategy sets out four Grand Challenges to put the UK at the forefront of industries of the future,  focused on global trends which will transform our future and include both the Ageing Society and AI. The UK is at the forefront of ageing research and development, for example the UK Dementia Research Institute is working to harness recent advances in artificial intelligence, engineering, robotics and sleep science to create new technologies that will deliver the highest quality dementia care in the home. The UK offers an unique opportunity for companies with innovative solutions for the ageing society to test, develop and grow.

UK’s Department for International Trade
12:45 – 13:00 UK case study: King’s College Longevity AI Consortium

Richard Siow, Director Ageing Research, (ARK) King’s College London

Use of artificial intelligence within longevity and ageing research is rapidly increasing in both academia and industry. To implement the latest AI advances and accelerate innovation and technology transfer, Ageing Research at King’s (ARK) has partnered with academic, charity, industry and policy partners to establish UK’s first Longevity AI Consortium (LAIC) at King’s College London. Advanced machine learning will be developed to provide robust biomarkers of longevity for diverse data types.

UK’s Department for International Trade
13:00 – 13:25 How to overcome Regulatory and Clinical Affairs Challenges in Digital Health and AI  (on-demand)

Beat U. Steffen, CEO, Confinis

Confinis
13:00 – 13:25 Technical Demo 

Mr. Jingqing Zhang, Head of AI, Pangaea Data

Dr. Zhihua Wang, Head of Product, Pangaea Data

Pangaea Data
13:20 –  13:50 Leveraging Causal AI to enhance Alzheimer’s Disease trials

Joydeep Sarkar, Chief Analytics Officer, Holmusk

Pascale Bouchard Cannon, Ph.D., Senior Data Scientist, Holmusk

Prof. Andreas U. Monsch, PhD, Head Memory Clinic, University Basel Department of Geriatric Medicine Felix Platter

Holmusk
14:00 – 14:15 Picomole Overview

Stehen Graham, CEO, Picomole

Invest in Canada
14:15 – 14:30 Digitize Value Chain to Enable Personalized Medicine

Florent Bouguin, Vice President, Chief Technology Officer, Optel Group

Invest in Canada
14:15 – 14:40 The Anatomy of Data-Driven Companies

Gian-Marco Baschera, Principal Consultant, Zühlke

Data-driven companies have come a long way in the past decade. What is it that distinguishes high-performing organisations and enables them to relentlessly create sustainable value from their data? What are their key capabilities and where will this journey lead to in the coming years? Our speaker, Gian-Marco Baschera, highlights technological and organisational success factors, best practices and emerging trends that set up companies onto the path to reap the benefits of being truly data-driven.

Zühlke
14:15 – 14:40 Clinical evidence and Digital Health (live)

Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis

Confinis
14:15 – 14:40 Making the Most from Healthcare data to Accelerate Scientific Research

Dr. Vibhor Gupta, Director and Founder, Pangaea Data

Pangaea Data
14:30 – 14:45 Accelerating Drug Discovery with Cyclica’s AI-Augmented Platform

Vern De Biasi, Global Head of Strategic Partnerships, Cyclica

Invest in Canada
14:45- 15:00 ProteinQure – Introduction and case study on designing de-novo binders for intracellular targets

Lucas Siow, Co-Founder & CEO, Proteinequer

Invest in Canada
15:00 – 15:15 emrchiver – A platform for migrating & enabling data from healthcare legacy systems.

Michael Lagowski, VP, Strategy & Product Development, Translucent Computing

Invest in Canada
15:00 – 16:00 Meet AlpVision – come with your questions!

Dr. Ewelina Kurtys, Scientist, AlpVision

AlpVision
15:15 – 15:30 Automating your Covid-19 Absence Management Efforts

Andrew Heneghan, EU Sales Consultant, Andgo 

Invest in Canada
15:30 – 15:45 Digital health solutions that help improve the lives of specialty patients and vulnerable populations with high unmet needs.

J. Manasse Theagene,  CEO, 360Medlink

Invest in Canada
15:45 – 16:00 Ultrasound + Artificial intelligence. Enabling the stethoscope of the 21st century.

David Quail, VP of Technology Commercialization, Medo.ai

Invest in Canada
16:00 – 16:15 Virtual collaboration around the patient

Alexandra T. Greenhill MD, CEO / CHIEF MEDICAL OFFICER, Careteam

Invest in Canada
16:15 – 16:30 The Power of Foresight

Amir Hayeri, CEO, bioconscious

Invest in Canada
16:30 – 16:45 Maryam Sadeghi, CEO, MetaOptima Invest in Canada
16:30 – 16:50 How to overcome Regulatory and Clinical Affairs Challenges in Digital Health and AI  (on-demand)

Beat U. Steffen, CEO, Confinis

Confinis
16:45 – 17:00 emtelligent – Transforming Healthcare with Medical NLP

Tim O’Connell, CEO,  Emtelligent

Invest in Canada